Company: We are Immutep, an emerging international biotechnology company developing immunotherapeutic products for cancer and autoimmune diseases. With operations based in Australia, Germany and France, Immutep is dedicated to bringing innovative treatment options to patients. The company is publicly traded on the ASX and NASDAQ. Location: Berlin, Germany; full-time, hybrid role (office/remote) Summary: As a […]